FORT LAUDERDALE, FL, March 01, 2018 -- SanSal Wellness Holdings, Inc. (“SanSal Wellness” or the “Company”) (OTCQB: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural phytocannabinoid-rich industrial hemp extracts, is pleased to provide this report highlighting the Company’s extensive use of third-party laboratory testing to verify the purity and potency of every SanSal Wellness wholesale and retail industrial hemp extract product.
“Third-party laboratory testing plays a very important role in our industrial hemp extract and finished product manufacturing process,” commented Rianna Meyer, Vice President of Operations at SanSal Wellness. “Not only does a consistent program of lab testing ensure that we are constantly in compliance with state and federal legal requirements to maintain THC levels lower than 0.3%, but it also helps us monitor the health of our crop and to accurately formulate finished products with the extracted cannabinoid-rich oil. With this strict testing process in place, our customers can feel confident that every SanSal Wellness product is contaminant free and contains the precise amounts of active compounds indicated each label.”
SanSal Wellness employs third-party laboratory testing at several key stages of production, including specific tests for potency, heavy metals, residual dissolved solvents, mold, and pesticides. SanSal first employs third-party testing from when the industrial hemp plants first enter the flowering stage. During this important growth phase, the crop is regularly monitored to ensure the plants are healthy and most importantly always remain below the legal limit of 0.3% THC mandated by the Colorado Department of Agriculture. Once the crop is ready to be harvested, it is cut, hung, and dried before extraction processing.
Following the extraction process, SanSal Wellness employs third-party laboratory tests on the “first-cut” oil extract. This cannabinoid potency testing once again confirms the required <0.3% THC and enables product formulators to accurately create the SanSal Wellness finished products like cannabinoid-rich tinctures, salves, lotions, etc. Additional third-party tests are conducted after each batch of finished products is completed.
Rianna Meyer concluded, “It’s very apparent that many hemp extract products on the market today don’t contain what they claim to and could never live up to the expectations of an informed consumer. One of the more important jobs that we have is to help educate the consumer that not all hemp extract products are created equal. By extensively using third-party lab testing to verify potency and purity at three distinct stages of production (flowering, extraction, and formulation), SanSal Wellness can produce the highest quality industrial hemp extract products and make consumers and wholesale buyers feel confident about what they are taking for themselves or recommending to friends and family.”
For additional information, visit www.sansalwellness.com.
About SanSal Wellness Holdings, Inc.
SanSal Wellness Holdings, Inc. (OTCQB: SSWH) is focused on producing superior quality, whole-plant, broad spectrum phytocannabinoid-rich hemp oils and extracts. SanSal Wellness currently operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.
Cautionary Language Concerning Forward-Looking Statements
This SanSal Wellness Holdings, Inc. press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.” Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update any of the information contained or referenced in this press release.
SanSal Wellness Holdings, Inc. - IR/Media Contact Toll-Free: (888) 549-7888 E-mail: [email protected]


SpaceX Turbine Push Unlikely to Threaten Howmet, Bernstein Says
ByteDance Secures $29.6 Billion Loan to Boost AI Investment
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability
Lynas Rare Earths Shares Rise After Takeover Talks Revealed
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada
Anthropic IPO Marketing Expected to Start in Mid-October
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks
Audi, SAIC Launch China Innovation Hub for New AUDI Models
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO
Xiaomi Shares Jump on Europe EV Expansion Plan
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns
South Korea, US Discuss Chip Investments Amid Tariff Plans
Milei Threatens Falkland Oil Firms With Sanctions 



